FoxP3 in Peripheral Blood Is Associated With Operational Tolerance in Liver Transplant Patients During Immunosuppression Withdrawal
The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Human liver allografts do sometimes survive in a recipient after withdrawal of immunosuppression (IS), commonly referred to as "operational tolerance." Preliminary clinical data have suggested an increase in the frequency of regulatory T cells (Treg) CD4+CD25 high and FoxP3 expression in operationally tolerant liver transplant recipients (Gr-T). In the context of human liver transplantation, the dynamics of Treg have not been studied. We designed a prospective study to ascertain the profile of the Treg population and FoxP3 expression during IS withdrawal. METHODS: To identify such parameters, we analyzed peripheral blood mononuclear cell populations and FoxP3 mRNA expression in 12 liver allograft recipients under cyclosporine A-based IS, who showed stable function of the allograft for more than 2 years. RESULTS: An increase was observed in the frequency of CD4+CD25 high cells when the IS was withdrawn in Gr-T patients (n=5). These patients exhibited a 3.5-fold increase for relative mRNA FoxP3 expression before the complete IS withdrawal and this continued when IS therapy was stopped. In patients who suffered rejection (n=7) there was no increase in the CD4+CD25 high cells or FoxP3 expression. CONCLUSIONS: With the present study, the first evidence is provided that the increase of CD4+CD25 high T cells and FoxP3 transcripts is associated with operational tolerance in liver transplanted patients during IS withdrawal.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“AR arises from an imbalance of immune activation (IA) related to cellular and humoral antidonor responses (e.g., effector CD4+, cytotoxic CD8+ T cells, and donor-specific antibodies) over immune quiescence (IQ) suppressor countermechanisms (e.g., regulatory T cells) (27–30).”
From The Blood Proteoform Atlas: A reference map of proteoforms in human hematopoietic cells (2022) · cites this paper as [29]
Citations
Cites
Control of Regulatory T Cell Development by the Transcription Factor Foxp3
Hori, S., Nomura, T., & Sakaguchi, S. (2003) · Science · doi:10.1126/science.1079490 · Cited by 8,187
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
Fontenot, J. D., Gavin, M. A., & Rudensky, A. Y. (2003) · Nature Immunology · doi:10.1038/ni904 · Cited by 7,745 · cited 2×
“FoxP3 was mainly expressed by CD4 CD25 Treg cells, currently representing the most definitive marker for this population (13, 16), and it is a key regulatory gene for the development of these cell subsets.”
BackgroundPark, J.-H., Adoro, S., Guinter, T., Erman, B., Alag, A. S., Catalfamo, M., Kimura, M. Y., Cui, Y., Lucas, P. J., Gress, R. E., et al. (2010) · Nature Immunology · doi:10.1038/ni.1840 · Cited by 5,835
Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M., & Toda, M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.3.1151 · Cited by 5,608
Regulatory T cells in transplantation tolerance
Wood, K. J., & Sakaguchi, S. (2003) · Nature Reviews Immunology · doi:10.1038/nri1027 · Cited by 1,317
Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25– T cells
R.Walker, M., Kasprowicz, D. J., Gersuk, V. H., Bènard, A., Van Landeghen, M., Buckner, J. H., & Ziegler, S. F. (2003) · Journal of Clinical Investigation · doi:10.1172/jci19441 · Cited by 1,245
Thornton, A. M., Donovan, E. E., Piccirillo, C. A., & Shevach, E. M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.11.6519 · Cited by 560
Molecular Mechanisms Underlying FOXP3 Induction in Human T Cells
Mantel, P.-Y., Ouaked, N., Rückert, B., Karagiannidis, C., Welz, R., Blaser, K., & Schmidt-Weber, C. B. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.6.3593 · Cited by 399
Multiparameter Immune Profiling of Operational Tolerance in Liver Transplantation
Martínez-Llordella, M., Puig-Pey, I., Orlando, G., Ramoni, M., Tisone, G., Rimola, A., Lerut, J., Latinne, D., Margarit, C., Bilbao, I., et al. (2007) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2006.01621.x · Cited by 374
WEANING OF IMMUNOSUPPRESSION IN LIVING DONOR LIVER TRANSPLANT RECIPIENTS1
Takatsuki, M., Uemoto, S., Inomata, Y., Egawa, H., Kiuchi, T., Fujita, S., Hayashi, M., Kanematsu, T., & Tanaka, K. (2001) · Transplantation · doi:10.1097/00007890-200108150-00016 · Cited by 296
Cited by
Items 101–179 of 179
Withdrawal of immunosuppression in liver transplantation and the mechanism of tolerance
Zhang, C., Wen, P., & Sun, Y. (2015) · Hepatobiliary & pancreatic diseases international · doi:10.1016/s1499-3872(15)60411-8 · Cited by 13
Desarrollo de inmunotolerancia en el trasplante hepático
Pons, J. A., Revilla‐Nuin, B., Ramı́rez, P., Baroja‐Mazo, A., & Parrilla, P. (2011) · Gastroenterología y Hepatología · doi:10.1016/j.gastrohep.2010.11.007 · Cited by 13
Self-citationNafady‐Hego, H., Li, Y., Ohe, H., Elgendy, H. M., Zhao, X., Sakaguchi, S., Bishop, G. A., & Koshiba, T. (2016) · Transplant Immunology · doi:10.1016/j.trim.2016.04.005 · Cited by 13
Navigating immune cell immunometabolism after liver transplantation
Zhang, W., Liu, Z., & Xu, X. (2021) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2021.103227 · Cited by 15
Lee, S. K., Kwon, J. H., Jang, J. W., Bae, S. H., Yoon, S. K., Jung, E. S., & Choi, J. Y. (2024) · Transplantation · doi:10.1097/tp.0000000000005220 · Cited by 13
“61,62 However, IFN-γ -deficient mouse liver allografts, having rejection at 15 d post-LT, showed similar levels of Treg along with a decrease in T-cell apoptosis compared with wild-type liver allografts.”
Current Status of Allograft Tolerance in Intestinal Transplantation
Meier, D., Rumbo, M., & Gondolesi, G. E. (2013) · International Reviews of Immunology · doi:10.3109/08830185.2013.829468 · Cited by 12
“A similar approach was developed by several groups on operational tolerant LTx patients, finding as common features an increase of plasmacytoid DC populations in peripheral blood [56], an increase of FoxP3+ T cells with suppressive capacity [57], and an increase of specific subsets of regulatory gamma delta T cells [5…”
MethodDuizendstra, A. A., de Knegt, R. J., Mancham, S., Klepper, M., Roelen, D. L., Brand‐Schaaf, S. H., Boor, P. P. C., Doukas, M., de Man, R. A., Sprengers, D., et al. (2021) · Liver Transplantation · doi:10.1002/lt.26188 · Cited by 13
Immune profiling and cancer post transplantation
Hope, C. M., Coates, P. T. H., & Carroll, R. P. (2015) · World Journal of Nephrology · doi:10.5527/wjn.v4.i1.41 · Cited by 12
Comprehensive phenotyping of regulatory T cells after liver transplantation
Álvarez, G., Fytili, P., Suneetha, P. V., Kraft, A. R. M., Brauner, C., Schlué, J., Krech, T., Lehner, F., Meyer-Heithuis, C., Jaeckel, E., et al. (2014) · Liver Transplantation · doi:10.1002/lt.24050 · Cited by 11
Regulatory T Cells in Transplantation: What We Know and What We Do Not Know
Yeung, M. Y., & Sayegh, M. H. (2009) · Transplantation Proceedings · doi:10.1016/j.transproceed.2009.06.093 · Cited by 11
Briem‐Richter, A., Leuschner, A., Haag, F., Grabhorn, E. F., & Ganschow, R. (2013) · Pediatric Transplantation · doi:10.1111/petr.12044 · Cited by 11
Cell Therapy as a Tool for Induction of Immunological Tolerance after Liver Transplantation
Kholodenko, I. V., Kholodenko, R. V., Lupatov, A. Y., & Yarygin, K. N. (2018) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-018-4213-8 · Cited by 9
Progress and challenges in diagnosis and treatment of rejection following liver transplantation
Florez, M. C., Bruner, J., & Zarrinpar, A. (2021) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0000000000000924 · Cited by 10
The value of microparticles in detecting acute rejection episodes after liver transplantation
Morgül, M. H., Splith, K., Leonhardt, C., Raschzok, N., Reutzel‐Selke, A., Schmuck, R. B., Andreou, A., Atanasov, G., Benzing, C., Krenzien, F., et al. (2017) · Biomarkers · doi:10.1080/1354750x.2017.1306754 · Cited by 9
Gagliani, N., Ferraro, A. M., Roncarolo, M. G., & Battaglia, M. (2009) · Immunology Letters · doi:10.1016/j.imlet.2009.07.007 · Cited by 11
Han, J. W., & Park, S. (2024) · Clinical Transplantation and Research · doi:10.4285/ctr.24.0059 · Cited by 8
“Another study demonstrated that patients with higher Treg levels were more likely to achieve operational tolerance, underscoring the potential of Tregs as a predictive biomarker of long-term transplant outcomes [55].”
Chruscinski, A. J., Rojas-Luengas, V., Moshkelgosha, S., Issachar, A., Luo, J., Yowanto, H., Lilly, L., Smith, R. W., Renner, E. L., Zhang, J., et al. (2021) · Clinical & Experimental Immunology · doi:10.1093/cei/uxab011 · Cited by 12
“expression in the peripheral blood in liver transplant recipients who successfully discontinued immunosuppressive therapy [33].”
BackgroundHong, S. K., Han, D., Lee, S., Kim, J., Hwang, E.-S., Kim, H., Lee, J.-I., Hong, K., Han, E. S., Cho, J., et al. (2021) · American Journal of Transplantation · doi:10.1111/ajt.16486 · Cited by 8
Duizendstra, A. A., de Knegt, R. J., Betjes, M. G. H., Coenen, S., Murad, S. D., de Man, R. A., Metselaar, H. J., Sprengers, D., Litjens, N. H. R., & Kwekkeboom, J. (2019) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000001435 · Cited by 8
Khalifian, S., Raimondi, G., Lee, W. A., & Brandacher, G. (2014) · Immunotherapy · doi:10.2217/imt.14.25 · Cited by 8
Gene Expression Profiling and Transplantation Tolerance in the Clinic
Benítez, C., Lozano, J. J., & Fueyo, A. S. (2009) · Transplantation · doi:10.1097/tp.0b013e3181af7d17 · Cited by 8
“(26) sequentially measured Foxp3 PBMC expression levels by qPCR on 12 liver recipients undergoing immunosuppression weaning.”
BackgroundAppenzeller‐Herzog, C., Rosat, A., Mathes, T., Baroja‐Mazo, A., Chruscinski, A. J., Feng, S., Herrero, J. I., Londoño, M., Mazariegos, G. V., Ohe, H., et al. (2023) · Liver International · doi:10.1111/liv.15764 · Cited by 7
Self-citationOperational tolerance in liver transplantation: Shall we predict or promote?
McCaughan, G. W., Bowen, D. G., & Bertolino, P. (2013) · Liver Transplantation · doi:10.1002/lt.23719 · Cited by 8
Pons, J. A., Revilla‐Nuin, B., Ramı́rez, P., Baroja‐Mazo, A., Martínez-Alarcón, L., Robles-Campos, R., Bueno, F. S., Ríos, A., Cascales-Campos, P. A., & Parrilla, P. (2012) · Transplantation Proceedings · doi:10.1016/j.transproceed.2012.05.026 · Cited by 6
Self-citationImmune Tolerance After Liver Transplantation
Feng, S., & Fueyo, A. S. (2019) · Springer eBooks · doi:10.1007/978-3-319-96400-3_36 · Cited by 7
Bontha, S. V., Piñeros-Fernandez, A., Maluf, D. G., & Mas, V. R. (2018) · Human Immunology · doi:10.1016/j.humimm.2018.01.008 · Cited by 9
Operational tolerance after liver transplantation, more common than we think: A case report
Benítez, C., Arancibia, J. P., Arrese, M. A., Soza, A., Domínguez, P., Jarufe, N., Martínez, J., & Pérez‐Ayuso, R. M. (2011) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31551-0 · Cited by 5
Duizendstra, A. A., van der Grift, M. V., Boor, P. P. C., Noordam, L., de Knegt, R. J., Peppelenbosch, M. P., Betjes, M. G. H., Litjens, N. H. R., & Kwekkeboom, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.738837 · Cited by 6
“Although previously higher expression of FOXP3 in blood of tolerant LTx recipients without IS compared to non-tolerant LTx recipients after reintroduction of IS regimen was reported, this difference was not observed when FOXP3 was measured before IS weaning (12, 13), supporting our observation that FOXP3 expression is…”
BackgroundResultCelaj, S., & Levitsky, J. (2020) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0000000000000834 · Cited by 5
Long-term Challenges After Solid Organ Transplantation
Legendre, C. M., Viebahn, R., Fehrman‐Ekholm, I., Masnou, N., Berenguer, M., Potena, L., Wennberg, L. M., O’Grady, J., Epailly, É., Diekmann, F., et al. (2018) · Transplantation · doi:10.1097/tp.0000000000002316 · Cited by 5
Peripheral biomarkers for individualizing immunosuppression in transplantation - Regulatory T cells
Schlickeiser, S., & Sawitzki, B. (2012) · Clinica Chimica Acta · doi:10.1016/j.cca.2012.02.010 · Cited by 5
Gama, J. F. G., Cardoso, L. M. D. F., Bisaggio, R. D. C., Lagrota-Cândido, J., Henriques‐Pons, A., & Alves, L. A. (2022) · Cells · doi:10.3390/cells11152327 · Cited by 4
Non‐invasive imaging of allogeneic transplanted skin graft by 131I‐anti‐TLR5 mAb
Sun, H., Yang, G., Liang, T. B., Zhang, C., Song, J., Han, J., & Hou, G. (2014) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12423 · Cited by 4
Chronic rejection after intestinal transplantation: A systematic review of experimental models
Kitamura, K., Buchholz, B. M., Abu-Elmagd, K. M., Kalff, J. C., Schäfer, N., & von Websky, M. W. (2019) · Transplantation Reviews · doi:10.1016/j.trre.2019.04.001 · Cited by 6
Shamsaeefar, A., Nikoupour, H., Kazemi, K., Gholami, S., Moosavi, S. A., Motazedian, N., Sayadi, M., Afshinnia, F., Nikeghbalian, S., & Malek‐Hosseini, S. A. (2021) · Transplant Immunology · doi:10.1016/j.trim.2021.101440 · Cited by 4
López-Díaz, G., Sánchez-Lorencio, M. I., Iñarrairaegui, M., Diéguez, M. L. G., Cadahía, V., Otero-Ferreiro, A., Vázquez-Millán, M. Á., Romero‐Cristóbal, M., Salcedo, M., Lorente-Pérez, S., et al. (2025) · PLoS ONE · doi:10.1371/journal.pone.0326442 · Cited by 5
“This contrasts with our 2008 findings [38], likely due to methodological differences: frozen peripheral blood mononuclear cells (PBMCs) in 2008 vs. stabilized whole blood RNA here, which better captures immune gene expression [39].”
Self-citationNam, N. H., Taura, K., Koyama, Y., Nishio, T., Yamamoto, G., Uemoto, Y., Kimura, Y., Xuefeng, L., Nakamura, D., Yoshino, K., et al. (2021) · Liver Transplantation · doi:10.1002/lt.26336 · Cited by 4
“postulated that the increase in FOXP3 expression in peripheral blood and its elevated messenger RNA (mRNA) expression are associated with tolerance during IS cessation.(25) In line with previously published results,(26,36) we describe here the immunological role of FOXP3 by detecting higher hepatic expression in patie…”
BackgroundResultDanger, R., Racapé, M., Soulillou, J., & Brouard, S. (2010) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0b013e32833bfac9 · Cited by 3
How to Estimate the Probability of Tolerance Long-Term in Liver Transplant Recipients
Eurich, D., Schlickeiser, S., Saidy, R. R. O., Uluk, D., Roßner, F., Postel, M. P., Schoening, W. N., Oellinger, R., Lurje, G., Pratschke, J., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12206546 · Cited by 4
Immunologic Monitoring to Personalize Immunosuppression After Liver Transplant
Zhu, A. X., Leto, A. C., Shaked, A. A., & Keating, B. J. (2018) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2018.01.003 · Cited by 3
Ravindranath, M. H., Hilali, F. E., & Filippone, E. J. (2021) · Vaccines · doi:10.3390/vaccines9060680 · Cited by 3
Strategies to Improve Immune Suppression Post-Liver Transplantation: A Review
Mohamed, I. B., Aloor, F. Z., & Jalal, P. K. (2021) · Transplantology · doi:10.3390/transplantology2040042 · Cited by 7
“5%% of 88 subjects 1, 2, 3, 4 years Levitsky [60] Adults Single center >3 years post-LTWithdrawal over 6 months 1255 >50% of 15 subjects 1 year”
BackgroundYeung, M. Y. (2011) · Springer eBooks · doi:10.1007/978-1-4614-0008-0_1 · Cited by 3
Identification of operationally tolerant liver transplant recipients
Fueyo, A. S. (2010) · Liver Transplantation · doi:10.1002/lt.22164 · Cited by 3
“Pons et al.18 recently published the results of the first study in which immunophenotypic analyses (in this case focused on the frequency of peripheral blood CD4þCD25þ T cells) were conducted before the initiation of IS weaning and repeated sequentially during the weaning phase.”
BackgroundManzia, T. M., Gazia, C., Baiocchi, L., Lenci, I., Milana, M., Santopaolo, F., Angelico, R., & Tisone, G. (2019) · Reviews on Recent Clinical Trials · doi:10.2174/1574887114666190313170205 · Cited by 2
Biomarkers of tolerance and immunological monitoring in liver transplantation
Евгеньевич, С. В., Боровкова, Н. В., & Новрузбеков, М. С. (2020) · Transplantologiya The Russian Journal of Transplantation · doi:10.23873/2074-0506-2020-12-2-126-134 · Cited by 2
Basic Understanding of Liver Transplant Immunology
Sharma, P., & Arora, A. (2023) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2023.05.007 · Cited by 2
Li, S., Wang, L., Bendersky, V. A., Gao, Q., Wang, J., Xu, H., & Kirk, A. D. (2024) · American Journal of Transplantation · doi:10.1016/j.ajt.2024.10.008 · Cited by 2
Vionnet, J., Miquel, R., Abraldeṣ, J. G., Lozano, J. J., Ruíz, P., Navasa, M., Marshall, A., Nevens, F., Gelson, W., Leithead, J., et al. (2025) · Efficacy and Mechanism Evaluation · doi:10.3310/fwxv5380 · Cited by 1
Clinical and Experimental Immune Tolerance in Pediatric Liver Transplantation
Elsabbagh, A. M., Hadjiyannis, Y., Vionnet, J., & Thomson, A. W. (2026) · Pediatric Transplantation · doi:10.1111/petr.70260 · Cited by 1
Engin, A., & Engin, A. B. (2015) · Molecular and integrative toxicology · doi:10.1007/978-3-319-15630-9_14 · Cited by 1
Онищенко, Н. А., Башкина, Л. В., Nicolskaya, A. O., & Артамонов, С. Д. (2014) · Russian Journal of Transplantology and Artificial Organs · doi:10.15825/1995-1191-2013-4-112-125 · Cited by 1
Tolerance in Liver Transplantation
Lim, T. Y., & Fueyo, A. S. (2022) · Springer eBooks · doi:10.1007/978-3-030-82930-8_45 · Cited by 1
Oellerich, M., Brandhorst, G., Shipkova, M., & Wieland, E. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-385467-4.00016-6 · Cited by 1
Clinical Transplantation Tolerance
Kawai, T., Sachs, D. H., & Cosimi, A. B. (2014) · doi:10.1002/9781118873434.ch76 · Cited by 1
Pons, J. A. (2013) · Gastroenterología y Hepatología · doi:10.1016/j.gastrohep.2013.07.001 · Cited by 1
Self-citationCAR Treg synergy with anti-CD154 mediates infectious tolerance to dictate heart transplant outcomesPreprint
Durgam, S. S., Rosado‐Sánchez, I., Yin, D., Speck, M., Mojibian, M., Sayin, I., Hynes, G. E., Alegre, M., Levings, M. K., & Chong, A. S. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.09.20.614149 · Cited by 1
Moraes‐Vieira, P. M. (2009) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2009.tde-10092009-114236
Takenaka, M. C. (2010) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2010.tde-03092010-105050
Tolerancia inmunológica en el trasplante hepático
Ramı́rez, P., Pons, J. A., Cascales-Campos, P. A., & Parrilla, P. (2011) · Medicina Clínica
Self-citationPerkins, J. D. (2009) · Liver Transplantation · doi:10.1002/lt.21829
Beyond fibrogenesis: Stellate cells take center stage as immune‐response modulators†
Bhatt, A. N., Adams, D., Kowdley, K. V., McCaughan, G. W., & Trautwein, C. (2009) · Hepatology · doi:10.1002/hep.23023
Linfócitos T : uma análise do perfil diferencial da expressão gênica na imunorregulação
Sousa, I. G. (2016) · RIUnB Institutional Repository (University of Brasília) · doi:10.26512/2016.11.t.20514
Immunological Biomarkers in Liver Transplantation
Solanas, E., Martínez-Crespo, E., Luè, A., Baptista, P. M., & Serrano, T. (2015) · Exposure and Health · doi:10.1007/978-94-007-7742-2_17-1
Immune monitoring of kidney transplant recipients with post-transplant malignancy.
Hope, C. M. (2014) · Adelaide Research & Scholarship (AR&S) (University of Adelaide)
Extracorporeal photopheresis in solid organ transplantation
Kildyushevsky, A. V., Moysyuk, Y. G., Molochkov, A. V., Mitina, T. A., & Faenko, A. P. (2020) · Almanac of Clinical Medicine · doi:10.18786/2072-0505-2020-48-046
Regulatory T Cells in the Mosaic of Liver Transplantation Tolerance
Terzieva, V. I., Uzunova, Y., Gornev, R., & Spassov, L. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.94362
中村, 祥., & ビートたけし (2006) · 新潮45
Prospects for Immune Tolerance
Fueyo, A. S., & Taylor, A. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-63671-1.00045-8
Immunological Biomarkers in Liver Transplantation
Solanas, E., Martínez-Crespo, E., Luè, A., Baptista, P. M., & Serrano, T. (2017) · Biomarkers in disease · doi:10.1007/978-94-007-7675-3_17
Zhang, C., Yuan, X., & Xie, K. (2025) · Cancers · doi:10.3390/cancers17233871 · Cited by 2
Wen, Y., Wang, X., Zhao, D., Zhou, T., Zong, Z., Gao, J., Zhang, J., Zhang, S., Gu, G., & Zhang, Z. (2026) · Fundamental Research · doi:10.1016/j.fmre.2026.01.002
Wang, R., Chen, T., Liu, Y., Zheng, W., Dong, C., Wang, K., Sun, C., Chen, J., Xie, E., Yang, Y., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1800926
Anti-Tumor Immunity in Solid-Organ Transplant Recipients
Wong, J. S. L., Li, K. H. L., Li, B., Leung, R. C., Yap, D. Y. H., Chan, A. C. Y., Cheung, T.-T., & Yau, T. C. C. (2026) · Cancers · doi:10.3390/cancers18081216
Induction of Clinical Operational Tolerance Through Immunosuppression Minimization: Less Is More?
Knioła, E., Foroncewicz, B., Lerut, J., Pączek, L., & Mucha, K. (2026) · Liver International · doi:10.1111/liv.70659
Guo, Y., Wang, L., Li, W., Liu, X., Liang, J., Song, M., Wang, X., Liu, Y., Li, Z., Li, S., et al. (2026) · Immunologic Research · doi:10.1007/s12026-026-09811-0
“…drug-discontinuation trial in liver transplant recipients with stable liver function for over 2 years revealed that successful discontinuers exhibited a sustained 3.5-fold increase in peripheral blood Foxp3 mRNA levels, whereas recipients experiencing rejection did not show this phenomenon [139 ].”
InfluentialImmunosuppression-Free Liver Transplantation
Manzia, T. M., Baiocchi, L., & Tisone, G. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-398523-1.00063-x
Metadata
- Authors
- Pons, J. A., Revilla-Nuin, B., Baroja-Mazo, A., Ramírez, P., Martínez-Alarcón, L., Sánchez-Bueno, F., Robles, R., Rios, A., Aparicio, P., & Parrilla, P.
- Affiliations
- Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (ES)
- Corresponding author
- Pons, José A.
- Venue
- Transplantation
- Published
- 2008-11-27
- Volume
- 86
- Issue
- 10
- Pages
- 1370-1378
- ISSN
- 0041-1337 (ISSN-L)
- OpenAlex
- W2075902442
- Cited by
- 179
- References
- 19
- Citations by year
- 2026: 6 · 2025: 4 · 2024: 6 · 2023: 3 · 2022: 7 · 2021: 19 · 2020: 11 · 2019: 7 · 2018: 8 · 2017: 8 · 2016: 12 · 2015: 7 · 2014: 11 · 2013: 16 · 2012: 15
- FWCI
- 5.27
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Transplantation (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
- Health Sciences › Medicine › Transplantation › Renal Transplantation Outcomes and Treatments
- Keywords
- Foxp3, regulatory T cells, operational tolerance, liver transplantation, immunosuppression withdrawal, cyclosporine, CD4+CD25high T cells, allograft rejection, peripheral blood mononuclear cells, Foxp3 mRNA expression
- MeSH terms
- Drug Administration Schedule, Female, Graft Survival, Humans, Immunosuppressive Agents, Liver Cirrhosis, Alcoholic, Male, Middle Aged, Retrospective Studies, RNA, Messenger, Substance Withdrawal Syndrome, Transplantation, Homologous, CD4-Positive T-Lymphocytes, Antigens, CD, Liver Transplantation, Cyclosporine, Transplantation Tolerance, T-Lymphocytes, Regulatory, Forkhead Transcription Factors, Interleukin-2 Receptor alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.